Keywords: Data Processing, Neuroinflammation
Motivation: The mechanisms through which gut microbiota alterations influence changes in brain metabolites in inflammatory bowel disease (IBD) remain poorly understood.
Goal(s): To investigate the relationship between levels of brain metabolites, specifically GABA and Glx, and gut microbiome alterations, along with clinical symptoms in IBD patients.
Approach: Magnetic resonance spectroscopy (MRS) and 16S rRNA sequencing were employed to assess brain metabolite levels and gut microbiota composition, respectively.
Results: Altered brain metabolites observed in IBD may be associated with dysbiosis of gut microbiota. These abnormalities are linked to sleep disturbances and pain experienced by IBD patients.
Impact: This study establishes a foundation for understanding the interaction mechanisms between gut microbiota and the central nervous system, offering valuable insights into the neural underpinnings of IBD-associated syndromes.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords